OBJECTIVE: We observed that estrogen did not show cardioprotective benefits in type 2 diabetic postmenopausal women. We hypothesized that hypertensive and/or overweight
women may be less likely to realize cardiovascular benefits from estrogen
CONCLUSIONS: Estrogen combined with synthetic progestin significantly improved flow-mediated brachial artery dilator response and reduced inflammation markers in hypertensive and/or overweight women, comparable to estrogen combined with natural progesterone.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!